Stem Cells

lt;b>Mariusz Z. Ratajczak, M.D., Ph.D, D.Sci d.hc is since 2001 the Henry and Stella Hoenig Endowed Chair in Cancer Biology and the Director of the Developmental Biology Research Program at the University of Louisville JGBCC. Dr. Ratajczak earned his M.D. at the Pomeranian Medical University  (1981) and his Ph.D. and D.Sci at the Polish Academy of Sciences in Warsaw, Poland and completed fellowships at the University of Pennsylvania in Philadelphia, USA. He is an internationally known investigator in the field of adult stem cell biology, molecular mechanism that regulate stem cell trafficking and biological effect of extracellular microvesciles. Among Dr. Ratajczak's prestigious awards are the 2014 Life achievement - Karl Landsteiner Award from the German Society of Transfusion Medicine and Immunohematotherapy, the 2008 Cancer Researcher of the Year award, the 2006 Award in Medicine and Biology from the Foundation for Polish Sciences, and the 2002 Chad Kopple Spirit Award from the Leukemia and Lymphoma Society. Dr. Ratajczak was honored with the degree, doctoris honoris causa, from the Medical University of Silesia. He is a visiting Professor at Kansai University in Osaka, Japan, Fudan University in China and Honorary Professor at Xiamen University, China. He has published more than 500 peer-reviewed publications and is a frequent speaker at conferences worldwide. His work is supported by NIH grants.

Stem cells and a hope for their potential clinical applications in regenerative medicine.- Genomic instability of iPSCs and challenges in their clinical applications.- Hematopoietic stem and progenitor cells (HSPCs).- Neural Stem Cells.- Therapeutic Potential of Mesenchymal Stem Cells in Immune-Mediated Diseases.- Stem Cells in the Mammalian Gonads.- Stem and progenitor cells in the pathogenesis and treatment of digestive diseases.- Stem cells in psychiatry.- The role of EVs as paracrine effectors in stem cell based therapies.- Cellular Therapy for Ischemic Heart Disease: An Update.- Vasculogenic stem and progenitor cells in human: Future cell therapy product or liquid biopsy for vascular disease?.- Epidermal Stem Cells.- Stem Cells in Lungs.- Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases.- Plausible links between metabolic networks, stem cells and longevity.- Index.